Log in to save to my catalogue

Long-term oral ACEI/ARB therapy is associated with disease severity in elderly COVID-19 omicron BA.2...

Long-term oral ACEI/ARB therapy is associated with disease severity in elderly COVID-19 omicron BA.2...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_276161025a534402a1e4d0d18679ef5b

Long-term oral ACEI/ARB therapy is associated with disease severity in elderly COVID-19 omicron BA.2 patients with hypertension

About this item

Full title

Long-term oral ACEI/ARB therapy is associated with disease severity in elderly COVID-19 omicron BA.2 patients with hypertension

Publisher

England: BioMed Central Ltd

Journal title

BMC infectious diseases, 2023-12, Vol.23 (1), p.882-882, Article 882

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

To explore the effects of long-term oral ACEIs/ARBs on the incidence of exacerbation and in-hospital mortality in elderly COVID-19 Omicron BA.2 patients with hypertension, especially patients aged 80 years or older.
In this retrospective study, patients suffering mild and rcommon COVID-19 with hypertension who were hospitalized in the Shanghai F...

Alternative Titles

Full title

Long-term oral ACEI/ARB therapy is associated with disease severity in elderly COVID-19 omicron BA.2 patients with hypertension

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_276161025a534402a1e4d0d18679ef5b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_276161025a534402a1e4d0d18679ef5b

Other Identifiers

ISSN

1471-2334

E-ISSN

1471-2334

DOI

10.1186/s12879-023-08913-6

How to access this item